Global Influenza Virus Vaccine (H1N1) Market Outlook 2022

SKU ID : QYR-19747597 | Publishing Date : 21-Dec-2021 | No. of pages : 115

Detailed TOC of Global Influenza Virus Vaccine (H1N1) Market Outlook 2022

1 Influenza Virus Vaccine (H1N1) Market Overview
    1.1 Product Overview and Scope of Influenza Virus Vaccine (H1N1)
    1.2 Influenza Virus Vaccine (H1N1) Segment by Type
        1.2.1 Global Influenza Virus Vaccine (H1N1) Sales Growth Rate Comparison by Type (2021-2027)
        1.2.2 Intramuscular Vaccine
        1.2.3 Nasal Spray Vaccine
    1.3 Influenza Virus Vaccine (H1N1) Segment by Application
        1.3.1 Global Influenza Virus Vaccine (H1N1) Sales Comparison by Application: (2021-2027)
        1.3.2 3 To 10 Years Old
        1.3.3 10 To 18 Years Old
        1.3.4 Above 18 Years Old
        1.3.5 Other
    1.4 Global Influenza Virus Vaccine (H1N1) Market Size Estimates and Forecasts
        1.4.1 Global Influenza Virus Vaccine (H1N1) Revenue 2016-2027
        1.4.2 Global Influenza Virus Vaccine (H1N1) Sales 2016-2027
        1.4.3 Influenza Virus Vaccine (H1N1) Market Size by Region: 2016 Versus 2021 Versus 2027

2 Influenza Virus Vaccine (H1N1) Market Competition by Manufacturers
    2.1 Global Influenza Virus Vaccine (H1N1) Sales Market Share by Manufacturers (2016-2021)
    2.2 Global Influenza Virus Vaccine (H1N1) Revenue Market Share by Manufacturers (2016-2021)
    2.3 Global Influenza Virus Vaccine (H1N1) Average Price by Manufacturers (2016-2021)
    2.4 Manufacturers Influenza Virus Vaccine (H1N1) Manufacturing Sites, Area Served, Product Type
    2.5 Influenza Virus Vaccine (H1N1) Market Competitive Situation and Trends
        2.5.1 Influenza Virus Vaccine (H1N1) Market Concentration Rate
        2.5.2 The Global Top 5 and Top 10 Largest Influenza Virus Vaccine (H1N1) Players Market Share by Revenue
        2.5.3 Global Influenza Virus Vaccine (H1N1) Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Influenza Virus Vaccine (H1N1) Retrospective Market Scenario by Region
    3.1 Global Influenza Virus Vaccine (H1N1) Retrospective Market Scenario in Sales by Region: 2016-2021
    3.2 Global Influenza Virus Vaccine (H1N1) Retrospective Market Scenario in Revenue by Region: 2016-2021
    3.3 North America Influenza Virus Vaccine (H1N1) Market Facts & Figures by Country
        3.3.1 North America Influenza Virus Vaccine (H1N1) Sales by Country
        3.3.2 North America Influenza Virus Vaccine (H1N1) Revenue by Country
        3.3.3 U.S.
        3.3.4 Canada
    3.4 Europe Influenza Virus Vaccine (H1N1) Market Facts & Figures by Country
        3.4.1 Europe Influenza Virus Vaccine (H1N1) Sales by Country
        3.4.2 Europe Influenza Virus Vaccine (H1N1) Revenue by Country
        3.4.3 Germany
        3.4.4 France
        3.4.5 U.K.
        3.4.6 Italy
        3.4.7 Russia
    3.5 Asia Pacific Influenza Virus Vaccine (H1N1) Market Facts & Figures by Region
        3.5.1 Asia Pacific Influenza Virus Vaccine (H1N1) Sales by Region
        3.5.2 Asia Pacific Influenza Virus Vaccine (H1N1) Revenue by Region
        3.5.3 China
        3.5.4 Japan
        3.5.5 South Korea
        3.5.6 India
        3.5.7 Australia
        3.5.8 Taiwan
        3.5.9 Indonesia
        3.5.10 Thailand
        3.5.11 Malaysia
        3.5.12 Philippines
        3.5.13 Vietnam
    3.6 Latin America Influenza Virus Vaccine (H1N1) Market Facts & Figures by Country
        3.6.1 Latin America Influenza Virus Vaccine (H1N1) Sales by Country
        3.6.2 Latin America Influenza Virus Vaccine (H1N1) Revenue by Country
        3.6.3 Mexico
        3.6.4 Brazil
        3.6.5 Argentina
    3.7 Middle East and Africa Influenza Virus Vaccine (H1N1) Market Facts & Figures by Country
        3.7.1 Middle East and Africa Influenza Virus Vaccine (H1N1) Sales by Country
        3.7.2 Middle East and Africa Influenza Virus Vaccine (H1N1) Revenue by Country
        3.7.3 Turkey
        3.7.4 Saudi Arabia
        3.7.5 UAE
4 Global Influenza Virus Vaccine (H1N1) Historic Market Analysis by Type
    4.1 Global Influenza Virus Vaccine (H1N1) Sales Market Share by Type (2016-2021)
    4.2 Global Influenza Virus Vaccine (H1N1) Revenue Market Share by Type (2016-2021)
    4.3 Global Influenza Virus Vaccine (H1N1) Price by Type (2016-2021)

5 Global Influenza Virus Vaccine (H1N1) Historic Market Analysis by Application
    5.1 Global Influenza Virus Vaccine (H1N1) Sales Market Share by Application (2016-2021)
    5.2 Global Influenza Virus Vaccine (H1N1) Revenue Market Share by Application (2016-2021)
    5.3 Global Influenza Virus Vaccine (H1N1) Price by Application (2016-2021)

6 Key Companies Profiled
    6.1 CSL
        6.1.1 CSL Corporation Information
        6.1.2 CSL Description and Business Overview
        6.1.3 CSL Influenza Virus Vaccine (H1N1) Sales, Revenue and Gross Margin (2016-2021)
        6.1.4 CSL Influenza Virus Vaccine (H1N1) Product Portfolio
        6.1.5 CSL Recent Developments/Updates
    6.2 NVS(Novartis)
        6.2.1 NVS(Novartis) Corporation Information
        6.2.2 NVS(Novartis) Description and Business Overview
        6.2.3 NVS(Novartis) Influenza Virus Vaccine (H1N1) Sales, Revenue and Gross Margin (2016-2021)
        6.2.4 NVS(Novartis) Influenza Virus Vaccine (H1N1) Product Portfolio
        6.2.5 NVS(Novartis) Recent Developments/Updates
    6.3 Sanofi Pasteur
        6.3.1 Sanofi Pasteur Corporation Information
        6.3.2 Sanofi Pasteur Description and Business Overview
        6.3.3 Sanofi Pasteur Influenza Virus Vaccine (H1N1) Sales, Revenue and Gross Margin (2016-2021)
        6.3.4 Sanofi Pasteur Influenza Virus Vaccine (H1N1) Product Portfolio
        6.3.5 Sanofi Pasteur Recent Developments/Updates
    6.4 Medimmune
        6.4.1 Medimmune Corporation Information
        6.4.2 Medimmune Description and Business Overview
        6.4.3 Medimmune Influenza Virus Vaccine (H1N1) Sales, Revenue and Gross Margin (2016-2021)
        6.4.4 Medimmune Influenza Virus Vaccine (H1N1) Product Portfolio
        6.4.5 Medimmune Recent Developments/Updates
    6.5 GSK
        6.5.1 GSK Corporation Information
        6.5.2 GSK Description and Business Overview
        6.5.3 GSK Influenza Virus Vaccine (H1N1) Sales, Revenue and Gross Margin (2016-2021)
        6.5.4 GSK Influenza Virus Vaccine (H1N1) Product Portfolio
        6.5.5 GSK Recent Developments/Updates
    6.6 Baxter
        6.6.1 Baxter Corporation Information
        6.6.2 Baxter Description and Business Overview
        6.6.3 Baxter Influenza Virus Vaccine (H1N1) Sales, Revenue and Gross Margin (2016-2021)
        6.6.4 Baxter Influenza Virus Vaccine (H1N1) Product Portfolio
        6.6.5 Baxter Recent Developments/Updates
    6.7 Beijing Kexing Bio-Vaccine
        6.6.1 Beijing Kexing Bio-Vaccine Corporation Information
        6.6.2 Beijing Kexing Bio-Vaccine Description and Business Overview
        6.6.3 Beijing Kexing Bio-Vaccine Influenza Virus Vaccine (H1N1) Sales, Revenue and Gross Margin (2016-2021)
        6.4.4 Beijing Kexing Bio-Vaccine Influenza Virus Vaccine (H1N1) Product Portfolio
        6.7.5 Beijing Kexing Bio-Vaccine Recent Developments/Updates
    6.8 Hualan Bio-Vaccine
        6.8.1 Hualan Bio-Vaccine Corporation Information
        6.8.2 Hualan Bio-Vaccine Description and Business Overview
        6.8.3 Hualan Bio-Vaccine Influenza Virus Vaccine (H1N1) Sales, Revenue and Gross Margin (2016-2021)
        6.8.4 Hualan Bio-Vaccine Influenza Virus Vaccine (H1N1) Product Portfolio
        6.8.5 Hualan Bio-Vaccine Recent Developments/Updates
    6.9 Changchun Changsheng Bio-Technology
        6.9.1 Changchun Changsheng Bio-Technology Corporation Information
        6.9.2 Changchun Changsheng Bio-Technology Description and Business Overview
        6.9.3 Changchun Changsheng Bio-Technology Influenza Virus Vaccine (H1N1) Sales, Revenue and Gross Margin (2016-2021)
        6.9.4 Changchun Changsheng Bio-Technology Influenza Virus Vaccine (H1N1) Product Portfolio
        6.9.5 Changchun Changsheng Bio-Technology Recent Developments/Updates
    6.10 Beijing Tiantan Bio-Products
        6.10.1 Beijing Tiantan Bio-Products Corporation Information
        6.10.2 Beijing Tiantan Bio-Products Description and Business Overview
        6.10.3 Beijing Tiantan Bio-Products Influenza Virus Vaccine (H1N1) Sales, Revenue and Gross Margin (2016-2021)
        6.10.4 Beijing Tiantan Bio-Products Influenza Virus Vaccine (H1N1) Product Portfolio
        6.10.5 Beijing Tiantan Bio-Products Recent Developments/Updates
    6.11 Jiangsu Yanshen Bio-Technology
        6.11.1 Jiangsu Yanshen Bio-Technology Corporation Information
        6.11.2 Jiangsu Yanshen Bio-Technology Influenza Virus Vaccine (H1N1) Description and Business Overview
        6.11.3 Jiangsu Yanshen Bio-Technology Influenza Virus Vaccine (H1N1) Sales, Revenue and Gross Margin (2016-2021)
        6.11.4 Jiangsu Yanshen Bio-Technology Influenza Virus Vaccine (H1N1) Product Portfolio
        6.11.5 Jiangsu Yanshen Bio-Technology Recent Developments/Updates
    6.12 Zhejiang Tianyuan Bio-Pharmaceutical
        6.12.1 Zhejiang Tianyuan Bio-Pharmaceutical Corporation Information
        6.12.2 Zhejiang Tianyuan Bio-Pharmaceutical Influenza Virus Vaccine (H1N1) Description and Business Overview
        6.12.3 Zhejiang Tianyuan Bio-Pharmaceutical Influenza Virus Vaccine (H1N1) Sales, Revenue and Gross Margin (2016-2021)
        6.12.4 Zhejiang Tianyuan Bio-Pharmaceutical Influenza Virus Vaccine (H1N1) Product Portfolio
        6.12.5 Zhejiang Tianyuan Bio-Pharmaceutical Recent Developments/Updates
    6.13 Dalian Yalifeng Bio-Pharmaceutical
        6.13.1 Dalian Yalifeng Bio-Pharmaceutical Corporation Information
        6.13.2 Dalian Yalifeng Bio-Pharmaceutical Influenza Virus Vaccine (H1N1) Description and Business Overview
        6.13.3 Dalian Yalifeng Bio-Pharmaceutical Influenza Virus Vaccine (H1N1) Sales, Revenue and Gross Margin (2016-2021)
        6.13.4 Dalian Yalifeng Bio-Pharmaceutical Influenza Virus Vaccine (H1N1) Product Portfolio
        6.13.5 Dalian Yalifeng Bio-Pharmaceutical Recent Developments/Updates
    6.14 Sinopharm
        6.14.1 Sinopharm Corporation Information
        6.14.2 Sinopharm Influenza Virus Vaccine (H1N1) Description and Business Overview
        6.14.3 Sinopharm Influenza Virus Vaccine (H1N1) Sales, Revenue and Gross Margin (2016-2021)
        6.14.4 Sinopharm Influenza Virus Vaccine (H1N1) Product Portfolio
        6.14.5 Sinopharm Recent Developments/Updates

7 Influenza Virus Vaccine (H1N1) Manufacturing Cost Analysis
    7.1 Influenza Virus Vaccine (H1N1) Key Raw Materials Analysis
       7.1.1 Key Raw Materials
       7.1.2 Key Suppliers of Raw Materials
    7.2 Proportion of Manufacturing Cost Structure
    7.3 Manufacturing Process Analysis of Influenza Virus Vaccine (H1N1)
    7.4 Influenza Virus Vaccine (H1N1) Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers
    8.1 Marketing Channel
    8.2 Influenza Virus Vaccine (H1N1) Distributors List
    8.3 Influenza Virus Vaccine (H1N1) Customers

9 Influenza Virus Vaccine (H1N1) Market Dynamics
    9.1 Influenza Virus Vaccine (H1N1) Industry Trends
    9.2 Influenza Virus Vaccine (H1N1) Growth Drivers
    9.3 Influenza Virus Vaccine (H1N1) Market Challenges
    9.4 Influenza Virus Vaccine (H1N1) Market Restraints

10 Global Market Forecast
    10.1 Influenza Virus Vaccine (H1N1) Market Estimates and Projections by Type
        10.1.1 Global Forecasted Sales of Influenza Virus Vaccine (H1N1) by Type (2022-2027)
        10.1.2 Global Forecasted Revenue of Influenza Virus Vaccine (H1N1) by Type (2022-2027)
    10.2 Influenza Virus Vaccine (H1N1) Market Estimates and Projections by Application
        10.2.1 Global Forecasted Sales of Influenza Virus Vaccine (H1N1) by Application (2022-2027)
        10.2.2 Global Forecasted Revenue of Influenza Virus Vaccine (H1N1) by Application (2022-2027)
    10.3 Influenza Virus Vaccine (H1N1) Market Estimates and Projections by Region
        10.3.1 Global Forecasted Sales of Influenza Virus Vaccine (H1N1) by Region (2022-2027)
        10.3.2 Global Forecasted Revenue of Influenza Virus Vaccine (H1N1) by Region (2022-2027)

11 Research Finding and Conclusion

12 Methodology and Data Source
    12.1 Methodology/Research Approach
        12.1.1 Research Programs/Design
        12.1.2 Market Size Estimation
        12.1.3 Market Breakdown and Data Triangulation
    12.2 Data Source
        12.2.1 Secondary Sources
        12.2.2 Primary Sources
    12.3 Author List
    12.4 Disclaimer

List of Figures, Tables and Charts Available in Global Influenza Virus Vaccine (H1N1) Market Outlook 2022

List of Tables
    Table 1. Global Influenza Virus Vaccine (H1N1) Sales (K Doses) Growth Rate Comparison by Type (2021-2027)
    Table 2. Global Influenza Virus Vaccine (H1N1) Sales (K Doses) Comparison by Application (2021-2027)
    Table 3. Global Influenza Virus Vaccine (H1N1) Market Size by Region (US$ Million) (2016 VS 2021 VS 2027)
    Table 4. Key Manufacturers Influenza Virus Vaccine (H1N1) Covered in This Study
    Table 5. Global Influenza Virus Vaccine (H1N1) Sales (K Doses) of Key Manufacturers (2016-2021)
    Table 6. Global Influenza Virus Vaccine (H1N1) Sales Market Share by Manufacturers (2016-2021)
    Table 7. Global Influenza Virus Vaccine (H1N1) Revenue (US$ Million) by Manufacturers (2016-2021)
    Table 8. Global Influenza Virus Vaccine (H1N1) Revenue Share by Manufacturers (2016-2021)
    Table 9. Global Market Influenza Virus Vaccine (H1N1) Average Price (US$/Dose) of Key Manufacturers (2016-2021)
    Table 10. Manufacturers Influenza Virus Vaccine (H1N1) Manufacturing Sites and Area Served
    Table 11. Manufacturers Influenza Virus Vaccine (H1N1) Product Type
    Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 13. Global Influenza Virus Vaccine (H1N1) by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Influenza Virus Vaccine (H1N1) as of 2020)
    Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 15. Global Influenza Virus Vaccine (H1N1) Sales by Region (2016-2021) & (K Doses)
    Table 16. Global Influenza Virus Vaccine (H1N1) Sales Market Share by Region (2016-2021)
    Table 17. Global Influenza Virus Vaccine (H1N1) Revenue by Region (2016-2021) & (US$ Million)
    Table 18. North America Influenza Virus Vaccine (H1N1) Sales by Country (2016-2021) & (K Doses)
    Table 19. North America Influenza Virus Vaccine (H1N1) Sales Market Share by Country (2016-2021)
    Table 20. North America Influenza Virus Vaccine (H1N1) Revenue by Country (2016-2021) & (US$ Million)
    Table 21. North America Influenza Virus Vaccine (H1N1) Revenue Market Share by Country (2016-2021)
    Table 22. Europe Influenza Virus Vaccine (H1N1) Sales by Country (2016-2021) & (K Doses)
    Table 23. Europe Influenza Virus Vaccine (H1N1) Sales Market Share by Country (2016-2021)
    Table 24. Europe Influenza Virus Vaccine (H1N1) Revenue by Country (2016-2021) & (US$ Million)
    Table 25. Europe Influenza Virus Vaccine (H1N1) Revenue Market Share by Country (2016-2021)
    Table 26. Asia Pacific Influenza Virus Vaccine (H1N1) Sales by Region (2016-2021) & (K Doses)
    Table 27. Asia Pacific Influenza Virus Vaccine (H1N1) Sales Market Share by Region (2016-2021)
    Table 28. Asia Pacific Influenza Virus Vaccine (H1N1) Revenue by Region (2016-2021) & (US$ Million)
    Table 29. Asia Pacific Influenza Virus Vaccine (H1N1) Revenue Market Share by Region (2016-2021)
    Table 30. Latin America Influenza Virus Vaccine (H1N1) Sales by Country (2016-2021) & (K Doses)
    Table 31. Latin America Influenza Virus Vaccine (H1N1) Sales Market Share by Country (2016-2021)
    Table 32. Latin America Influenza Virus Vaccine (H1N1) Revenue by Country (2016-2021) & (US$ Million)
    Table 33. Latin America Influenza Virus Vaccine (H1N1) Revenue Market Share by Country (2016-2021)
    Table 34. Middle East and Africa Influenza Virus Vaccine (H1N1) Sales by Country (2016-2021) & (K Doses)
    Table 35. Middle East and Africa Influenza Virus Vaccine (H1N1) Sales Market Share by Country (2016-2021)
    Table 36. Middle East and Africa Influenza Virus Vaccine (H1N1) Revenue by Country (2016-2021) & (US$ Million)
    Table 37. Middle East and Africa Influenza Virus Vaccine (H1N1) Revenue Market Share by Country (2016-2021)
    Table 38. Global Influenza Virus Vaccine (H1N1) Sales (K Doses) by Type (2016-2021)
    Table 39. Global Influenza Virus Vaccine (H1N1) Sales Market Share by Type (2016-2021)
    Table 40. Global Influenza Virus Vaccine (H1N1) Revenue (Million US$) by Type (2016-2021)
    Table 41. Global Influenza Virus Vaccine (H1N1) Revenue Share by Type (2016-2021)
    Table 42. Global Influenza Virus Vaccine (H1N1) Price (US$/Dose) by Type (2016-2021)
    Table 43. Global Influenza Virus Vaccine (H1N1) Sales (K Doses) by Application (2016-2021)
    Table 44. Global Influenza Virus Vaccine (H1N1) Sales Market Share by Application (2016-2021)
    Table 45. Global Influenza Virus Vaccine (H1N1) Revenue (Million US$) by Application (2016-2021)
    Table 46. Global Influenza Virus Vaccine (H1N1) Revenue Share by Application (2016-2021)
    Table 47. Global Influenza Virus Vaccine (H1N1) Price (US$/Dose) by Application (2016-2021)
    Table 48. CSL Corporation Information
    Table 49. CSL Description and Business Overview
    Table 50. CSL Influenza Virus Vaccine (H1N1) Sales (K Doses), Revenue (Million US$), Price (US$/Dose) and Gross Margin (2016-2021)
    Table 51. CSL Influenza Virus Vaccine (H1N1) Product
    Table 52. CSL Recent Developments/Updates
    Table 53. NVS(Novartis) Corporation Information
    Table 54. NVS(Novartis) Description and Business Overview
    Table 55. NVS(Novartis) Influenza Virus Vaccine (H1N1) Sales (K Doses), Revenue (Million US$), Price (US$/Dose) and Gross Margin (2016-2021)
    Table 56. NVS(Novartis) Influenza Virus Vaccine (H1N1) Product
    Table 57. NVS(Novartis) Recent Developments/Updates
    Table 58. Sanofi Pasteur Corporation Information
    Table 59. Sanofi Pasteur Description and Business Overview
    Table 60. Sanofi Pasteur Influenza Virus Vaccine (H1N1) Sales (K Doses), Revenue (Million US$), Price (US$/Dose) and Gross Margin (2016-2021)
    Table 61. Sanofi Pasteur Influenza Virus Vaccine (H1N1) Product
    Table 62. Sanofi Pasteur Recent Developments/Updates
    Table 63. Medimmune Corporation Information
    Table 64. Medimmune Description and Business Overview
    Table 65. Medimmune Influenza Virus Vaccine (H1N1) Sales (K Doses), Revenue (Million US$), Price (US$/Dose) and Gross Margin (2016-2021)
    Table 66. Medimmune Influenza Virus Vaccine (H1N1) Product
    Table 67. Medimmune Recent Developments/Updates
    Table 68. GSK Corporation Information
    Table 69. GSK Description and Business Overview
    Table 70. GSK Influenza Virus Vaccine (H1N1) Sales (K Doses), Revenue (Million US$), Price (US$/Dose) and Gross Margin (2016-2021)
    Table 71. GSK Influenza Virus Vaccine (H1N1) Product
    Table 72. GSK Recent Developments/Updates
    Table 73. Baxter Corporation Information
    Table 74. Baxter Description and Business Overview
    Table 75. Baxter Influenza Virus Vaccine (H1N1) Sales (K Doses), Revenue (Million US$), Price (US$/Dose) and Gross Margin (2016-2021)
    Table 76. Baxter Influenza Virus Vaccine (H1N1) Product
    Table 77. Baxter Recent Developments/Updates
    Table 78. Beijing Kexing Bio-Vaccine Corporation Information
    Table 79. Beijing Kexing Bio-Vaccine Description and Business Overview
    Table 80. Beijing Kexing Bio-Vaccine Influenza Virus Vaccine (H1N1) Sales (K Doses), Revenue (Million US$), Price (US$/Dose) and Gross Margin (2016-2021)
    Table 81. Beijing Kexing Bio-Vaccine Influenza Virus Vaccine (H1N1) Product
    Table 82. Beijing Kexing Bio-Vaccine Recent Developments/Updates
    Table 83. Hualan Bio-Vaccine Corporation Information
    Table 84. Hualan Bio-Vaccine Description and Business Overview
    Table 85. Hualan Bio-Vaccine Influenza Virus Vaccine (H1N1) Sales (K Doses), Revenue (Million US$), Price (US$/Dose) and Gross Margin (2016-2021)
    Table 86. Hualan Bio-Vaccine Influenza Virus Vaccine (H1N1) Product
    Table 87. Hualan Bio-Vaccine Recent Developments/Updates
    Table 88. Changchun Changsheng Bio-Technology Corporation Information
    Table 89. Changchun Changsheng Bio-Technology Description and Business Overview
    Table 90. Changchun Changsheng Bio-Technology Influenza Virus Vaccine (H1N1) Sales (K Doses), Revenue (Million US$), Price (US$/Dose) and Gross Margin (2016-2021)
    Table 91. Changchun Changsheng Bio-Technology Influenza Virus Vaccine (H1N1) Product
    Table 92. Changchun Changsheng Bio-Technology Recent Developments/Updates
    Table 93. Beijing Tiantan Bio-Products Corporation Information
    Table 94. Beijing Tiantan Bio-Products Description and Business Overview
    Table 95. Beijing Tiantan Bio-Products Influenza Virus Vaccine (H1N1) Sales (K Doses), Revenue (Million US$), Price (US$/Dose) and Gross Margin (2016-2021)
    Table 96. Beijing Tiantan Bio-Products Influenza Virus Vaccine (H1N1) Product
    Table 97. Beijing Tiantan Bio-Products Recent Developments/Updates
    Table 98. Jiangsu Yanshen Bio-Technology Corporation Information
    Table 99. Jiangsu Yanshen Bio-Technology Description and Business Overview
    Table 100. Jiangsu Yanshen Bio-Technology Influenza Virus Vaccine (H1N1) Sales (K Doses), Revenue (Million US$), Price (US$/Dose) and Gross Margin (2016-2021)
    Table 101. Jiangsu Yanshen Bio-Technology Influenza Virus Vaccine (H1N1) Product
    Table 102. Jiangsu Yanshen Bio-Technology Recent Developments/Updates
    Table 103. Zhejiang Tianyuan Bio-Pharmaceutical Corporation Information
    Table 104. Zhejiang Tianyuan Bio-Pharmaceutical Description and Business Overview
    Table 105. Zhejiang Tianyuan Bio-Pharmaceutical Influenza Virus Vaccine (H1N1) Sales (K Doses), Revenue (Million US$), Price (US$/Dose) and Gross Margin (2016-2021)
    Table 106. Zhejiang Tianyuan Bio-Pharmaceutical Influenza Virus Vaccine (H1N1) Product
    Table 107. Zhejiang Tianyuan Bio-Pharmaceutical Recent Developments/Updates
    Table 108. Dalian Yalifeng Bio-Pharmaceutical Corporation Information
    Table 109. Dalian Yalifeng Bio-Pharmaceutical Description and Business Overview
    Table 110. Dalian Yalifeng Bio-Pharmaceutical Influenza Virus Vaccine (H1N1) Sales (K Doses), Revenue (Million US$), Price (US$/Dose) and Gross Margin (2016-2021)
    Table 111. Dalian Yalifeng Bio-Pharmaceutical Influenza Virus Vaccine (H1N1) Product
    Table 112. Dalian Yalifeng Bio-Pharmaceutical Recent Developments/Updates
    Table 113. Sinopharm Corporation Information
    Table 114. Sinopharm Description and Business Overview
    Table 115. Sinopharm Influenza Virus Vaccine (H1N1) Sales (K Doses), Revenue (Million US$), Price (US$/Dose) and Gross Margin (2016-2021)
    Table 116. Sinopharm Influenza Virus Vaccine (H1N1) Product
    Table 117. Sinopharm Recent Developments/Updates
    Table 118. Production Base and Market Concentration Rate of Raw Material
    Table 119. Key Suppliers of Raw Materials
    Table 120. Influenza Virus Vaccine (H1N1) Distributors List
    Table 121. Influenza Virus Vaccine (H1N1) Customers List
    Table 122. Influenza Virus Vaccine (H1N1) Market Trends
    Table 123. Influenza Virus Vaccine (H1N1) Growth Drivers
    Table 124. Influenza Virus Vaccine (H1N1) Market Challenges
    Table 125. Influenza Virus Vaccine (H1N1) Market Restraints
    Table 126. Global Influenza Virus Vaccine (H1N1) Sales Forecast by Type (2022-2027) & (K Doses)
    Table 127. Global Influenza Virus Vaccine (H1N1) Sales Market Share Forecast by Type (2022-2027)
    Table 128. Global Influenza Virus Vaccine (H1N1) Revenue Forecast by Type (2022-2027) & (US$ Million)
    Table 129. Global Influenza Virus Vaccine (H1N1) Revenue Market Share Forecast by Type (2022-2027)
    Table 130. Global Influenza Virus Vaccine (H1N1) Sales Forecast by Application (2022-2027) & (K Doses)
    Table 131. Global Influenza Virus Vaccine (H1N1) Sales Market Share Forecast by Application (2022-2027)
    Table 132. Global Influenza Virus Vaccine (H1N1) Revenue Forecast by Application (2022-2027) & (US$ Million)
    Table 133. Global Influenza Virus Vaccine (H1N1) Revenue Market Share Forecast by Application (2022-2027)
    Table 134. Global Influenza Virus Vaccine (H1N1) Sales Forecast by Region (2022-2027) & (K Doses)
    Table 135. Global Influenza Virus Vaccine (H1N1) Sales Market Share Forecast by Region (2022-2027)
    Table 136. Global Influenza Virus Vaccine (H1N1) Revenue Forecast by Region (2022-2027) & (US$ Million)
    Table 137. Global Influenza Virus Vaccine (H1N1) Revenue Market Share Forecast by Region (2022-2027)
    Table 138. Research Programs/Design for This Report
    Table 139. Key Data Information from Secondary Sources
    Table 140. Key Data Information from Primary Sources
List of Figures
    Figure 1. Product Picture of Influenza Virus Vaccine (H1N1)
    Figure 2. Global Influenza Virus Vaccine (H1N1) Market Share by Type in 2020 & 2027
    Figure 3. Intramuscular Vaccine Product Picture
    Figure 4. Nasal Spray Vaccine Product Picture
    Figure 5. Global Influenza Virus Vaccine (H1N1) Market Share by Application in 2020 & 2027
    Figure 6. 3 To 10 Years Old
    Figure 7. 10 To 18 Years Old
    Figure 8. Above 18 Years Old
    Figure 9. Other
    Figure 10. Global Influenza Virus Vaccine (H1N1) Revenue, (US$ Million), 2016 VS 2021 VS 2027
    Figure 11. Global Influenza Virus Vaccine (H1N1) Market Size 2016-2027 (US$ Million)
    Figure 12. Global Influenza Virus Vaccine (H1N1) Sales 2016-2027 (K Doses)
    Figure 13. Global Influenza Virus Vaccine (H1N1) Market Size Market Share by Region: 2016 VS 20210 VS 2027
    Figure 14. Influenza Virus Vaccine (H1N1) Sales Share by Manufacturers in 2020
    Figure 15. Global Influenza Virus Vaccine (H1N1) Revenue Share by Manufacturers in 2020
    Figure 16. The Global 5 and 10 Largest Influenza Virus Vaccine (H1N1) Players: Market Share by Revenue in 2020
    Figure 17. Influenza Virus Vaccine (H1N1) Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021
    Figure 18. Global Influenza Virus Vaccine (H1N1) Sales Market Share by Region (2016-2021)
    Figure 19. Global Influenza Virus Vaccine (H1N1) Sales Market Share by Region in 2020
    Figure 20. Global Influenza Virus Vaccine (H1N1) Revenue Market Share by Region (2016-2021)
    Figure 21. Global Influenza Virus Vaccine (H1N1) Revenue Market Share by Region in 2020
    Figure 22. U.S. Influenza Virus Vaccine (H1N1) Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 23. Canada Influenza Virus Vaccine (H1N1) Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 24. Germany Influenza Virus Vaccine (H1N1) Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 25. France Influenza Virus Vaccine (H1N1) Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 26. U.K. Influenza Virus Vaccine (H1N1) Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 27. Italy Influenza Virus Vaccine (H1N1) Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 28. Russia Influenza Virus Vaccine (H1N1) Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 29. China Influenza Virus Vaccine (H1N1) Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 30. Japan Influenza Virus Vaccine (H1N1) Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 31. South Korea Influenza Virus Vaccine (H1N1) Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 32. India Influenza Virus Vaccine (H1N1) Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 33. Australia Influenza Virus Vaccine (H1N1) Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 34. Taiwan Influenza Virus Vaccine (H1N1) Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 35. Indonesia Influenza Virus Vaccine (H1N1) Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 36. Thailand Influenza Virus Vaccine (H1N1) Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 37. Malaysia Influenza Virus Vaccine (H1N1) Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 38. Philippines Influenza Virus Vaccine (H1N1) Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 39. Vietnam Influenza Virus Vaccine (H1N1) Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 40. Mexico Influenza Virus Vaccine (H1N1) Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 41. Brazil Influenza Virus Vaccine (H1N1) Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 42. Argentina Influenza Virus Vaccine (H1N1) Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 43. Turkey Influenza Virus Vaccine (H1N1) Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 44. Saudi Arabia Influenza Virus Vaccine (H1N1) Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 45. UAE Influenza Virus Vaccine (H1N1) Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 46. Sales Market Share of Influenza Virus Vaccine (H1N1) by Type (2016-2021)
    Figure 47. Sales Market Share of Influenza Virus Vaccine (H1N1) by Application (2016-2021)
    Figure 48. Sales Market Share of Influenza Virus Vaccine (H1N1) by Application in 2020
    Figure 49. Revenue Share of Influenza Virus Vaccine (H1N1) by Application (2016-2021)
    Figure 50. Revenue Share of Influenza Virus Vaccine (H1N1) by Application in 2020
    Figure 51. Manufacturing Cost Structure of Influenza Virus Vaccine (H1N1)
    Figure 52. Manufacturing Process Analysis of Influenza Virus Vaccine (H1N1)
    Figure 53. Influenza Virus Vaccine (H1N1) Industrial Chain Analysis
    Figure 54. Channels of Distribution
    Figure 55. Distributors Profiles
    Figure 56. Bottom-up and Top-down Approaches for This Report
    Figure 57. Data Triangulation
    Figure 58. Key Executives Interviewed

Keyplayers in Global Influenza Virus Vaccine (H1N1) Market Outlook 2022

CSL
NVS(Novartis)
Sanofi Pasteur
Medimmune
GSK
Baxter
Beijing Kexing Bio-Vaccine
Hualan Bio-Vaccine
Changchun Changsheng Bio-Technology
Beijing Tiantan Bio-Products
Jiangsu Yanshen Bio-Technology
Zhejiang Tianyuan Bio-Pharmaceutical
Dalian Yalifeng Bio-Pharmaceutical
Sinopharm